Search research articles
Contact Us
Filters
Showing results (221-230 of 337) with videos related to
Page
of 34
Sort By:
Virchows Archiv : an International Journal of Pathology
|
January 25, 2020
Reproducibility of histologic prognostic parameters for mantle cell lymphoma: cytology, Ki67, p53 and SOX11
Giorgio A Croci, Eva Hoster, Sílvia Beà, et al.
The Lancet. Oncology
|
June 9, 2020
Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND): a multicentre, prospective, single-arm, phase 2 study
Gilles Salles, Johannes Duell, Eva González Barca, et al.
Blood Advances
|
June 23, 2026
Loss of miR-146a-5p contributes to ibrutinib resistance in mantle cell lymphoma
Olga Kersy, Nir Cohen, Mali Salmon-Divon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 22, 2023
Predictive Value of Minimal Residual Disease for Efficacy of Rituximab Maintenance in Mantle Cell Lymphoma: Results From the European Mantle Cell Lymphoma Elderly Trial
Eva Hoster, Marie-Hélène Delfau-Larue, Elizabeth Macintyre, et al.
Hemasphere
|
November 15, 2019
Is Good Clinical Practice Becoming Poor Clinical Care?
Steven Le Gouill, Martin Dreyling, Maria Dolores Caballero, et al.
British Journal of Haematology
|
October 10, 2017
Optimization of rituximab for the treatment of DLBCL: increasing the dose for elderly male patients
Michael Pfreundschuh, Niels Murawski, Samira Zeynalova, et al.
Hemasphere
|
April 15, 2022
Outcome of COVID-19 in Patients With Mantle Cell Lymphoma-Report From the European MCL Registry
Marie-Kristin Tilch, Carlo Visco, Sandra Kinda, et al.
Leukemia
|
August 27, 2022
Response to "The WHO classification of haematolymphoid tumours" (Editorial)
Steven H Swerdlow, Elias Campo, Daniel A Arber, et al.
Hemasphere
|
February 27, 2023
A Lack of Diversity, Equity, and Inclusion in Clinical Research Has Direct Impact on Patient Care
Tarec Christoffer El-Galaly, Verena I Gaidzik, Mihnea-Alexandru Gaman, et al.
Future Oncology (London, England)
|
November 15, 2022
BRUIN MCL-321: phase III study of pirtobrutinib versus investigator choice of BTK inhibitor in BTK inhibitor naive mantle cell lymphoma
Toby A Eyre, Nirav N Shah, Martin Dreyling, et al.
Page
of 34
Search research articles
Search
Showing results (221-230 of 337) with videos related to
Sort By:
Page
of 34
Virchows Archiv : an International Journal of Pathology
|
January 25, 2020
Reproducibility of histologic prognostic parameters for mantle cell lymphoma: cytology, Ki67, p53 and SOX11
Giorgio A Croci, Eva Hoster, Sílvia Beà, et al.
The Lancet. Oncology
|
June 9, 2020
Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND): a multicentre, prospective, single-arm, phase 2 study
Gilles Salles, Johannes Duell, Eva González Barca, et al.
Blood Advances
|
June 23, 2026
Loss of miR-146a-5p contributes to ibrutinib resistance in mantle cell lymphoma
Olga Kersy, Nir Cohen, Mali Salmon-Divon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 22, 2023
Predictive Value of Minimal Residual Disease for Efficacy of Rituximab Maintenance in Mantle Cell Lymphoma: Results From the European Mantle Cell Lymphoma Elderly Trial
Eva Hoster, Marie-Hélène Delfau-Larue, Elizabeth Macintyre, et al.
Hemasphere
|
November 15, 2019
Is Good Clinical Practice Becoming Poor Clinical Care?
Steven Le Gouill, Martin Dreyling, Maria Dolores Caballero, et al.
British Journal of Haematology
|
October 10, 2017
Optimization of rituximab for the treatment of DLBCL: increasing the dose for elderly male patients
Michael Pfreundschuh, Niels Murawski, Samira Zeynalova, et al.
Hemasphere
|
April 15, 2022
Outcome of COVID-19 in Patients With Mantle Cell Lymphoma-Report From the European MCL Registry
Marie-Kristin Tilch, Carlo Visco, Sandra Kinda, et al.
Leukemia
|
August 27, 2022
Response to "The WHO classification of haematolymphoid tumours" (Editorial)
Steven H Swerdlow, Elias Campo, Daniel A Arber, et al.
Hemasphere
|
February 27, 2023
A Lack of Diversity, Equity, and Inclusion in Clinical Research Has Direct Impact on Patient Care
Tarec Christoffer El-Galaly, Verena I Gaidzik, Mihnea-Alexandru Gaman, et al.
Future Oncology (London, England)
|
November 15, 2022
BRUIN MCL-321: phase III study of pirtobrutinib versus investigator choice of BTK inhibitor in BTK inhibitor naive mantle cell lymphoma
Toby A Eyre, Nirav N Shah, Martin Dreyling, et al.
Page
of 34